Skip to main content
SpringerLink
Log in

Rheumatische Krankheiten

  • Chapter
Die ärztliche Begutachtung

Zusammenfassung

Die Ursache systemisch entzündlich rheumatischer Erkrankungen ist für die meisten Krankheitsentitäten nicht geklärt. Bei genetisch Disponierten kommen physikalische, chemische, infektiöse oder andere äußere Ereignisse als auslösende oder verschlimmernde, den Krankheitsverlauf modulierende Faktoren in Frage. Autoimmunologische Prozesse und systemische Entzündung prägen das klinische Bild.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

Zu 16.1

  1. Aletaha D, Landewe R, et al. (2008) “Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 67:1360–1364

    Article  PubMed  CAS  Google Scholar 

  2. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588

    Article  PubMed  Google Scholar 

  3. Banal F, Dougados M, et al. (2009) Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis. Ann Rheum Dis 68:1184–1191

    Article  PubMed  CAS  Google Scholar 

  4. Barton JL, Criswell LA, et al. (2009) Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis. J Rheumatol 36:2635–2641

    Article  PubMed  Google Scholar 

  5. Bijlsma JW (2010) Optimal treatment of rheumatoid arthritis: EULAR recommendations for clinical practice. Pol Arch Med Wewn 120:347–353

    PubMed  CAS  Google Scholar 

  6. Bingham CO 3rd, Pohl C, et al. (2009) Developing a standardized definition for disease “flare” in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol 36:2335–2341

    Article  PubMed  Google Scholar 

  7. Cannella AC, O’Dell JR (2006) Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials. Drugs 66:1319–1337

    Article  PubMed  CAS  Google Scholar 

  8. Fritze E, Schröder W, Dickmans H (1962) Rheumatische Reaktionslage und Pneumokoniose. Rundherdpneumokoniose bei Rheumatismus nodosus. Z Rheumaforschung 21:61–70

    CAS  Google Scholar 

  9. Funovits J, Aletaha D, et al. (2010) The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 69:1589–1595

    Article  PubMed  Google Scholar 

  10. Graudal N, Jurgens G (2010) Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons. Arthritis Rheum 62:2852–2863

    Article  PubMed  CAS  Google Scholar 

  11. Hersh A, Yazdany J (2009) Clinical practice guidelines and diagnostic uncertainty in the management of early rheumatoid arthritis. J Rheumatol 36:863–864

    Article  PubMed  Google Scholar 

  12. Karonitsch T, Aletaha D, et al. (2008) Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis. Ann Rheum Dis 67:1365–1373

    Article  PubMed  CAS  Google Scholar 

  13. Kavanaugh A (2010) Rheumatoid arthritis: Guidelines for RA therapy-avoiding hamartia. Nat Rev Rheumatol 6:505–506

    Article  PubMed  Google Scholar 

  14. Mochan E, Ebell MH (2008) Predicting rheumatoid arthritis risk in adults with undifferentiated arthritis. Am Fam Physician 77:1451–1453

    PubMed  Google Scholar 

  15. Neogi T, Aletaha D, et al. (2010) The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum 62:2582–2591

    Article  PubMed  Google Scholar 

  16. O’Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med 350:2591–2602

    Article  PubMed  Google Scholar 

  17. van Tuyl LH, Vlad SC, et al. (2009) Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference. Arthritis Rheum 61:704–710

    Article  PubMed  Google Scholar 

  18. Walker D, Hall S (2010) NICE guidance on rheumatoid arthritis: implications and challenges for rheumatologists. Rheumatology (Oxford) 49:619–620

    Article  Google Scholar 

Zu 16.2

  1. Bader-Meunier B, Wouters C, et al. (2010). Guidelines for diagnosis and treatment of oligoarticular and polyarticular juvenile idiopathic arthritis. Arch Pediatr 17:1085–1089

    Article  PubMed  CAS  Google Scholar 

  2. Beresford MW, Cleary AG, et al. (2010) Comment on: Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 49: 2227–2229

    Article  Google Scholar 

  3. Huppertz HI (2011) Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: comment on the article by Beukelman et al. Arthritis Care Res (Hoboken) 63:1354–1355; author reply 1355–1356

    Article  Google Scholar 

  4. Stanley LC, Ward-Smith P (2011) The diagnosis and management of juvenile idiopathic arthritis. J Pediatr Health Care 25:191–194

    Article  PubMed  Google Scholar 

  5. Wallace CA (2010) Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 49:1213–1214

    Article  Google Scholar 

Zu 16.6

  1. Feist E, Hansen A (2010) Critical overview of outcome parameters for patients with primary Sjogren’s syndrome. Z Rheumatol 69:25–31

    Article  PubMed  CAS  Google Scholar 

  2. Seror R, Ravaud P, et al. (2010) EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69:1103–1109

    Article  PubMed  Google Scholar 

  3. Seror R, Ravaud P, et al. (2011) EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome.” Ann Rheum Dis 70:968–972

    Article  PubMed  Google Scholar 

Zu 16.9

  1. White KP, Speechley M, Harth M, Ostbye T (1999) Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 42:76–83

    Article  PubMed  CAS  Google Scholar 

Zu 16.12

  1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049

    Article  PubMed  CAS  Google Scholar 

  2. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514

    Article  PubMed  CAS  Google Scholar 

  3. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. (1995) Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 38:1535–1540

    Article  PubMed  CAS  Google Scholar 

  4. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. (1995) Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 38:1541–1546

    Article  PubMed  CAS  Google Scholar 

  5. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JWJ, Dieppe P, et al. (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62:1145–1155

    Article  PubMed  CAS  Google Scholar 

  6. Recommendations for the medical management of osteoarthritis of the hip and knee (2000) Update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43:1905–1915

    Article  Google Scholar 

  7. Schnitzer TJ (2002) Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage 23(4 Suppl):S24–S30

    Article  PubMed  Google Scholar 

Zu 16.15

  1. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268:2069–2073

    Google Scholar 

  2. Jansen TL, Janssen M, de Jong AJ, Jeurissen ME (1999) Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 245:261–267

    Article  PubMed  CAS  Google Scholar 

Zu 16.16

  1. Simon L, Lipman A, Jacox A, Caudill-Slosberg M, Gill M, Keefe F, et al. (2002) Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis, 2nd ed. Glenview IL (ed) American Pain Society

    Google Scholar 

Zu 16.17

  1. Brockmöller J, Eis DD, Mühlinghaus T, Meineke C, Birkner N (2003) Untersuchungen zur Suszeptibilität bei multipler Chemikalienüberempfindlichkeit (MCS). Abschlußbericht im Auftrag des Bundesumweltamtes

    Google Scholar 

  2. Buchwald D, Ashley RL, Pearlman T, et al. (1996) Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J Med Virol 50:25–30

    Article  PubMed  CAS  Google Scholar 

  3. Bundesministerium für Arbeit und Soziales (Hrsg) (2009) Versorgungsmedizin-Verordnung – VersMedV – in der jeweils gültigen Fassung (www.bmas.de), zuletzt geändert mit Wirkung vom 28. 10. 2011. In: BGBl. I vom 4. 11. 2011, S 2153; www.bgbl.de

    Google Scholar 

  4. Bundesministerium für Gesundheit und Soziale Sicherung (Hrsg) (2004) Anhaltspunkte für die ärztliche Gutachtertätigkeit im sozialen Entschädiungsrecht und nach dem Schwerbehindertenrecht

    Google Scholar 

  5. Chambers D, Bagnall AM, Hempel S, Forbes C (2006) Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R SocMed 99:506–520

    Article  Google Scholar 

  6. Eis D, Dietel A, Mühlinghaus T, Birkner N, Jordan L, Meineke C, Renner B in Zusammenarbeit mit dem Deutschen MCS-Forschungsverbund (2005) Studie zum Verlauf und zur Prognose des MCS-Syndroms – Erweiterung der Basisstichprobe und Nachuntersuchung. Abschlussbericht im Auftrag des Bundesumweltamtes

    Google Scholar 

  7. Fukuda K, Straus SE, Hickie I, et al. (1994) The chronic fatigue syndrome: A comprehensive approach to its defition and study. International Chronic Fatigue Syndrome Study Group [see comments]. Ann Int Med 121:953–959

    PubMed  CAS  Google Scholar 

  8. Hausotter W (2004) Begutachtung somatoformer und funktioneller Störungen. Urban & Fischer, Stuttgart

    Google Scholar 

  9. Lombardi VC, Ruscetti FW, Gupta JD, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (New York, N.Y) 326:585–589; doi: 10.1126/science.1179052

    Article  CAS  Google Scholar 

  10. Maschewsky W (1998) Chemikalienunverträglichkeit und Beruf – Ergebnisse einer empirischen Studie. Z Umweltmedizin 6: Heft 5/98; http://www2.bremen.de/info/oekoaerztebund/maschews.htm

    Google Scholar 

  11. Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, Leite JC, Poland F, Howe A, Drachler ML (2011) Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med 9:91

    Article  PubMed  Google Scholar 

  12. Neeck G, Crofford LJ (2000) Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrom: Rheum Dis Clin North Am 26:989–1002

    Article  PubMed  CAS  Google Scholar 

  13. Nix WA, Egle UT (1998) Das chronische Erschöpfbarkeitssyndrom. Akt Neurol 25:6–12

    Article  Google Scholar 

  14. Parker AJ, Wessely S, Cleare AJ (2001) The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 31:1331–1345

    PubMed  CAS  Google Scholar 

  15. van Kuppeveld FJM, de Jong AS, Lanke KH, Verhaegh GW, Melchers WJG, Swanink CMA, Bleijenberg G, Netea MG, Galama JMD, van der Meer JWM (2010) Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 340:c1018; doi:10.1136/bmj.c1018

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Innere Medizin – Rheumatologie, Klaus-Miehlke-Klinik, Leibnizstraße 23, 65191, Wiesbaden, Deutschland

    Wolfgang W. Bolten Dr. med.

  2. Verband der Privaten Krankenversicherung e. V., Gustav-Heinemann-Ufer 74c, 50968, Köln, Deutschland

    Jürgen Fritze Prof. Dr.

Authors
  1. Wolfgang W. Bolten Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Fritze Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universität Frankfurt am Main, Pulheim, Deutschland

    Jürgen Fritze Prof. Dr.

  2. Deutsche Gesetzliche Unfallversicherung (DGUV), Berlin, Deutschland

    Friedrich Mehrhoff Dr. jur.

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bolten, W., Fritze, J. (2012). Rheumatische Krankheiten. In: Fritze, J., Mehrhoff, F. (eds) Die ärztliche Begutachtung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21081-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21081-5_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21080-8

  • Online ISBN: 978-3-642-21081-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation